期刊
CELL STEM CELL
卷 10, 期 6, 页码 717-728出版社
CELL PRESS
DOI: 10.1016/j.stem.2012.05.007
关键词
-
资金
- Australian National Health and Medical Research Council (NHMRC)
- Victorian State Government through Victorian Cancer Agency of the Victorian Breast Cancer Research Consortium
- OIS
- NHMRC IRIISS
The cancer stem cell (CSC) model has been established as a cellular mechanism that contributes to phenotypic and functional heterogeneity in diverse cancer types. Recent observations, however, have highlighted many complexities and challenges: the CSC phenotype can vary substantially between patients, tumors may harbor multiple phenotypically or genetically distinct CSCs, metastatic CSCs can evolve from primary CSCs, and tumor cells may undergo reversible phenotypic changes. Although the CSC concept will have clinical relevance in specific cases, accumulating evidence suggests that it will be imperative to target all CSC subsets within the tumor to prevent relapse.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据